AU3060500A - 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments - Google Patents

1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments

Info

Publication number
AU3060500A
AU3060500A AU30605/00A AU3060500A AU3060500A AU 3060500 A AU3060500 A AU 3060500A AU 30605/00 A AU30605/00 A AU 30605/00A AU 3060500 A AU3060500 A AU 3060500A AU 3060500 A AU3060500 A AU 3060500A
Authority
AU
Australia
Prior art keywords
asmedicaments
diazacycloheptane
compounds
preparation
use asmedicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30605/00A
Inventor
Bipinchandra Bhudharlal Chaudhari
Richard Alan Keith
Charles David Mclaren
Richard Elliot Simon-Bierenbaum
Edward John Warawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca UK Ltd filed Critical AstraZeneca UK Ltd
Publication of AU3060500A publication Critical patent/AU3060500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU30605/00A 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments Abandoned AU3060500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9900078.8A GB9900078D0 (en) 1999-01-05 1999-01-05 Chemical compounds
GB9900078 1999-01-05
PCT/GB1999/004351 WO2000040574A1 (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use as medicaments

Publications (1)

Publication Number Publication Date
AU3060500A true AU3060500A (en) 2000-07-24

Family

ID=10845530

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30605/00A Abandoned AU3060500A (en) 1999-01-05 1999-12-21 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments

Country Status (5)

Country Link
EP (1) EP1140891A1 (en)
JP (1) JP2003507323A (en)
AU (1) AU3060500A (en)
GB (1) GB9900078D0 (en)
WO (1) WO2000040574A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9914015D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914025D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
US7923444B2 (en) 2005-02-10 2011-04-12 Neurosearch A/S Alkyl substituted homopiperazine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN112375005A (en) * 2019-08-16 2021-02-19 国药集团工业有限公司 Racemization method of ketamine, its derivative or its salt

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2064514B (en) * 1979-10-29 1984-01-18 Maruko Pharmaceutical Co Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
DE3823533A1 (en) * 1988-07-12 1990-02-08 Beiersdorf Ag SUBSTITUTED 4-HETEROCYCLYL-2H-BENZO (B) PYRANEES, METHOD AND 4-HYDROXY-3-BROM, 3,4-OXIRANYL-3,4-DEHYDRO-2H-BENZO (B) PYRANES AS INTERMEDIATE PRODUCTS FOR THEIR MANUFACTURE, AND THE INVENTION PHARMACEUTICAL PRECAUTIONS CONTAINING THEM
FR2687401B1 (en) * 1992-02-18 1994-05-20 Meram Laboratoires 1,4-DIALKYLPIPERAZINE DERIVATIVES, PROCESSES FOR OBTAINING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
KR20000022380A (en) * 1996-07-01 2000-04-25 둘락 노먼 씨. Muscarinic antagonists
CA2226058C (en) * 1997-01-30 2008-01-29 F. Hoffmann-La Roche Ag 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives

Also Published As

Publication number Publication date
GB9900078D0 (en) 1999-02-24
EP1140891A1 (en) 2001-10-10
WO2000040574A1 (en) 2000-07-13
JP2003507323A (en) 2003-02-25

Similar Documents

Publication Publication Date Title
AU3958100A (en) New compounds, their preparation and use
AU3958200A (en) New compounds, their preparation and use
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU3957900A (en) New compounds, their preparation and use
AU2001262723A1 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof
AU6190199A (en) New compounds, their preparation and use
AU6190299A (en) New compounds, their preparation and use
AU3595099A (en) New compounds, their preparation and use
AU5426500A (en) Benzazepine derivatives, process for the preparation of the same and uses thereof
AU7972200A (en) Process for the preparation of urea
AU2466700A (en) Process for the preparation of urea
AU7446900A (en) Thioalkylamine derivatives and process for the preparation thereof
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
AU6480299A (en) Pharmaceutical compounds
AU2943400A (en) Process for the preparation of alpha-aminoketone derivatives
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
AU3060500A (en) 1,4-diazacycloheptane compounds, process for their preparation, and their use asmedicaments
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU2207001A (en) Novel compounds and process
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU2155501A (en) Process for the preparation of ketimines
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU2002242348A1 (en) Process for obtaining 3'-epilutein
AU5982199A (en) Process for the preparation of 4,4'-dihalogen-o-hydroxydiphenyl compounds
AU4263799A (en) Pyridyl-pyrazole derivatives, process for their preparation, and their use as herbicides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase